相关实验视频
Updated: Jun 9, 2025
09:38
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
2.0K
用托法西提尼布治疗的抗性 Vitiligo 在停止治疗后持续复原色素
1Department of Dermatology, Rutgers New Jersey Medical School, Newark, NJ; Rs1520@njms.rutgers.eduto.
Skinmed
|October 21, 2024
概括
口服托法西提尼布在64岁的女性中有效治疗白风,显示出持续的改善. 治疗导致一些盆腔和大腿,这是唯一的不良反应.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- Vitiligo 是一种慢性自身免疫性疾病,其特征是色素脱落的斑块.
- 传统的治疗方法,如局部类固醇和NB-UVB,对于广泛的白风通常具有有限的疗效.
研究的目的:
- 评估口服托法西提尼布在治疗白病中的疗效和安全性.
主要方法:
- 一名64岁的白病患者接受了口服托法西提尼布5毫克每天两次的治疗.
- 治疗反应和不良反应被监测了几个月.
主要成果:
- 在开始服用口服托法西提尼布后,观察到白病的持续改善.
- 患者报告说,她的骨盆和大腿上的增加是唯一的不良事件.
结论:
- 口服托法西提尼布显示出作为白风有效治疗的潜力.
- 需要进一步的研究来确认托法西提尼布在更大的白风队列中的有效性和安全性概况.
相关概念视频
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97